WallStreetZenWallStreetZen

NASDAQ: COEP
Coeptis Therapeutics Holdings Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Coeptis Therapeutics Holdings earnings were -$16.1M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest COEP earnings report on Jun 30, 2024 announced Q2 2024 earnings of -$3.0M, up 1.1% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, COEP reported annual earnings of -$21.3M, with -43.4% growth.

COEP earnings history

Current Revenue
$0.0
Current Earnings
-$16.1M
Current Profit Margin
0%

COEP Return on Equity

Current Company
-5,746.6%
Current Industry
22.8%
Current Market
33.7%
COEP's Return on Equity (-487.6%)... subscribe to Premium to read more.
High Return on Equity Performance

COEP Return on Assets

Current Company
-372.5%
Current Industry
3.5%
COEP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when COEP announces earnings.

COEP Return on Capital Employed

Current Company
-2,766.09%
Current Industry
21.3%
COEP's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

COEP vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
COEP-$14.84M-$16.14MN/A-$0.47
TFFP-$18.85M-$19.39MN/A-$7.47
SNGX-$7.71M-$7.04MN/A-$9.31
MBIO-$30.63M-$32.06MN/A-$2.75
ADXN$5.67M$5.08MN/A$0.05
View Top Biotech Stocks

Coeptis Therapeutics Holdings Earnings Reports & History FAQ

What were Coeptis Therapeutics Holdings's earnings last quarter?

Coeptis Therapeutics Holdings (NASDAQ: COEP) reported Q2 2024 earnings per share (EPS) of -$0.08, up 46.67% year over year. Total COEP earnings for the quarter were -$3.04 million. In the same quarter last year, Coeptis Therapeutics Holdings's earnings per share (EPS) was -$0.15.

If you're new to stock investing, here's how to buy Coeptis Therapeutics Holdings stock.

Is Coeptis Therapeutics Holdings profitable or losing money?

As of the last Coeptis Therapeutics Holdings earnings report, Coeptis Therapeutics Holdings is currently losing money. Coeptis Therapeutics Holdings's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$16.14 million, a 18.27% decrease year over year.

What was COEP's earnings growth in the past year?

As of Coeptis Therapeutics Holdings's earnings date in Q4 2024, Coeptis Therapeutics Holdings's earnings has grown year over year. COEP earnings in the past year totalled -$16.14 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.